These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

914 related articles for article (PubMed ID: 33772767)

  • 41. Human post-infection serological response to the spike and nucleocapsid proteins of SARS-CoV-2.
    Xiao C; Ling S; Qiu M; Deng Z; Chen L; Zhu A; Chen Y; Liu Y; Lin X; Lin F; Wu Q; Shen L; Ye F; Liu X; Li Y; Zhao J; Yang Z; Cowling BJ; Webby R; Zanin M; Wong SS
    Influenza Other Respir Viruses; 2021 Jan; 15(1):7-12. PubMed ID: 32844604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19.
    Dugas M; Grote-Westrick T; Merle U; Fontenay M; Kremer AE; Hanses F; Vollenberg R; Lorentzen E; Tiwari-Heckler S; Duchemin J; Ellouze S; Vetter M; Fürst J; Schuster P; Brix T; Denkinger CM; Müller-Tidow C; Schmidt H; Tepasse PR; Kühn J
    J Clin Virol; 2021 Jun; 139():104847. PubMed ID: 33965698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests.
    De Marco Verissimo C; O'Brien C; López Corrales J; Dorey A; Cwiklinski K; Lalor R; Doyle JM; Field S; Masterson C; Ribes Martinez E; Hughes G; Bergin C; Walshe K; McNicholas B; Laffey JG; Dalton JP; Kerr C; Doyle S
    Epidemiol Infect; 2021 Jun; 149():e140. PubMed ID: 34099081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19.
    Flinck H; Rauhio A; Luukinen B; Lehtimäki T; Haapala AM; Seiskari T; Aittoniemi J
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115197. PubMed ID: 32977117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide.
    Woo PC; Lau SK; Wong BH; Chan KH; Hui WT; Kwan GS; Peiris JS; Couch RB; Yuen KY
    J Clin Microbiol; 2004 Dec; 42(12):5885-8. PubMed ID: 15583332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monoclonal Antibodies to S and N SARS-CoV-2 Proteins as Probes to Assess Structural and Antigenic Properties of Coronaviruses.
    Kumar R; Christensen ND; Kaddis Maldonado RJ; Bewley MC; Ostman A; Sudol M; Chen EC; Buchkovich NW; Gontu A; Surendran Nair M; Nissly RH; Minns AM; Kapur V; Rossi R; Kuchipudi SV; Lindner SE; Parent LJ; Flanagan JM; Buchkovich NJ
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696329
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Humoral response to spike S1 and S2 and nucleocapsid proteins on microarray after SARS-CoV-2 infection.
    Portilho AI; Silva VO; Ahagon CM; Matsuda EM; de Oliveira EL; da Silveira EPR; de Souza Lima AK; Lindoso JAL; de Campos IB; Hong MA; De Gaspari E; de Macedo Brígido LF
    J Med Virol; 2022 Jan; 94(1):178-185. PubMed ID: 34428312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serological differentiation between COVID-19 and SARS infections.
    Chia WN; Tan CW; Foo R; Kang AEZ; Peng Y; Sivalingam V; Tiu C; Ong XM; Zhu F; Young BE; Chen MI; Tan YJ; Lye DC; Anderson DE; Wang LF
    Emerg Microbes Infect; 2020 Dec; 9(1):1497-1505. PubMed ID: 32529906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epitope profiling reveals binding signatures of SARS-CoV-2 immune response in natural infection and cross-reactivity with endemic human CoVs.
    Stoddard CI; Galloway J; Chu HY; Shipley MM; Sung K; Itell HL; Wolf CR; Logue JK; Magedson A; Garrett ME; Crawford KHD; Laserson U; Matsen FA; Overbaugh J
    Cell Rep; 2021 May; 35(8):109164. PubMed ID: 33991511
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
    Fenwick C; Croxatto A; Coste AT; Pojer F; André C; Pellaton C; Farina A; Campos J; Hacker D; Lau K; Bosch BJ; Gonseth Nussle S; Bochud M; D'Acremont V; Trono D; Greub G; Pantaleo G
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33144321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
    Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
    Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses.
    Jiang HW; Li Y; Zhang HN; Wang W; Yang X; Qi H; Li H; Men D; Zhou J; Tao SC
    Nat Commun; 2020 Jul; 11(1):3581. PubMed ID: 32665645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Humoral and Cellular Immune Response to SARS-CoV-2 S and N Proteins.
    Afridonova ZE; Toptygina AP; Mikhaylov IS
    Biochemistry (Mosc); 2024 May; 89(5):872-882. PubMed ID: 38880648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity.
    Becker M; Strengert M; Junker D; Kaiser PD; Kerrinnes T; Traenkle B; Dinter H; Häring J; Ghozzi S; Zeck A; Weise F; Peter A; Hörber S; Fink S; Ruoff F; Dulovic A; Bakchoul T; Baillot A; Lohse S; Cornberg M; Illig T; Gottlieb J; Smola S; Karch A; Berger K; Rammensee HG; Schenke-Layland K; Nelde A; Märklin M; Heitmann JS; Walz JS; Templin M; Joos TO; Rothbauer U; Krause G; Schneiderhan-Marra N
    Nat Commun; 2021 Feb; 12(1):1152. PubMed ID: 33608538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Profile of specific antibodies to the SARS-CoV-2.
    Mou D; Feng H; Cao R; Weng X; Zhao L; Yang L; Jin R; Chen W
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33734961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of immunodominant epitopes on nucleocapsid and spike proteins of the SARS-CoV-2 in Iranian COVID-19 patients.
    Maghsood F; Shokri MR; Jeddi-Tehrani M; Torabi Rahvar M; Ghaderi A; Salimi V; Kardar GA; Zarnani AH; Amiri MM; Shokri F
    Pathog Dis; 2022 Feb; 80(1):. PubMed ID: 34994386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination.
    Hu C; Wang Z; Ren L; Hao Y; Zhu M; Jiang H; Wang S; Li D; Shao Y
    Front Cell Infect Microbiol; 2022; 12():978440. PubMed ID: 36118022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nucleocapsid and Spike Protein-Based Anti-SARS-CoV-2 Assay Performance in the Minority and Rural Coronavirus Insights Study: Characteristics of Socioeconomically Disadvantaged Populations with Health Disparities.
    Christenson RH; Hansel S; II'yasova D; Meyer WA; Puckrein G; Lee L; Landry LG; Akinboboye O
    J Appl Lab Med; 2024 May; 9(3):493-501. PubMed ID: 38384143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.